Ubs Oconnor LLC Savara Inc Transaction History

Ubs Oconnor LLC

$1.46 Billion
Q3 2024

A detailed history of Ubs Oconnor LLC transactions in Savara Inc stock. As of the latest transaction made, Ubs Oconnor LLC holds 38,482 shares of SVRA stock, worth $125,451. This represents 0.01% of its overall portfolio holdings.

Number of Shares

38,482

Holding current value

$125,451

% of portfolio

0.01%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.96 - $5.07 $21,764 - $27,864	-5,496 Reduced 12.5%	38,482 $163,000
Q2 2024 Aug 14, 2024	SELL	$3.66 - $5.34 $159,059 - $232,071	-43,459 Reduced 49.7%	43,978 $177,000
Q1 2024 May 15, 2024	SELL	$4.19 - $5.59 $374,791 - $500,019	-89,449 Reduced 50.57%	87,437 $435,000
Q4 2023 Feb 14, 2024	SELL	$3.18 - $4.9 $647,021 - $996,983	-203,466 Reduced 53.49%	176,886 $831,000
Q3 2023 Nov 14, 2023	SELL	$2.97 - $3.88 $59,400 - $77,600	-20,000 Reduced 5.0%	380,352 $1.44 Million
Q2 2023 Aug 14, 2023	BUY	$1.69 - $3.24 $676,594 - $1.3 Million	400,352 New	400,352 $1.28 Billion
Q1 2023 May 15, 2023	BUY	$1.6 - $2.82 $168,115 - $296,303	105,072 Added 23.27%	556,513 $1.09 Million
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.64 $78,378 - $115,802	70,611 Added 18.54%	451,441 $0
Q3 2022 Nov 14, 2022	BUY	$1.36 - $1.88 $254,972 - $352,462	187,480 Added 96.96%	380,830 $590 Million
Q2 2022 Aug 12, 2022	BUY	$1.1 - $1.58 $212,685 - $305,493	193,350 New	193,350 $293,000

Others Institutions Holding SVRA

# of Institutions

129

Shares Held

158M

Call Options Held

67.6K

Put Options Held

29.4K

Nea Management Company, LLC Timonium, MD

24.5M
Shares

$79.8 Million
7.93% of portfolio
Bain Capital Life Sciences Investors, LLC Boston, MA

14.6M
Shares

$47.5 Million
11.08% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

12.4M
Shares

$40.3 Million
6.8% of portfolio
Wellington Management Group LLP Boston, MA

8.62M
Shares

$28.1 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

8.16M
Shares

$26.6 Million
1.86% of portfolio

View Full List

About Savara Inc

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $372M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

More about SVRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.

Account